Matt O'Brien
Stock Analyst at Piper Sandler
(2.08)
# 2,842
Out of 5,182 analysts
204
Total ratings
38.92%
Success rate
-6.66%
Average return
Main Sectors:
Stocks Rated by Matt O'Brien
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADGM Adagio Medical Holdings | Initiates: Overweight | $3 | $1.05 | +185.71% | 1 | Apr 14, 2026 | |
| MDT Medtronic | Maintains: Neutral | $105 → $91 | $79.37 | +14.65% | 10 | Apr 1, 2026 | |
| MMED MiniMed Group | Initiates: Neutral | $16 | $12.02 | +33.11% | 1 | Mar 31, 2026 | |
| TELA TELA Bio | Maintains: Neutral | $1.25 → $1 | $0.86 | +16.28% | 8 | Mar 25, 2026 | |
| CNMD CONMED | Downgrades: Neutral | $55 → $39 | $35.96 | +8.45% | 15 | Mar 17, 2026 | |
| TNDM Tandem Diabetes Care | Upgrades: Overweight | $21 → $33 | $18.16 | +81.72% | 11 | Mar 17, 2026 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $50 → $28 | $21.71 | +28.97% | 6 | Feb 26, 2026 | |
| TMDX TransMedics Group | Maintains: Overweight | $140 → $160 | $98.57 | +62.32% | 14 | Feb 25, 2026 | |
| GMED Globus Medical | Reiterates: Overweight | $90 → $115 | $87.79 | +30.99% | 13 | Jan 8, 2026 | |
| KMTS Kestra Medical Technologies | Maintains: Overweight | $27 → $30 | $19.51 | +53.77% | 2 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $18 | $12.28 | +46.58% | 2 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $75 | $57.56 | +30.30% | 13 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $20 → $25 | $9.30 | +168.82% | 4 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $26 → $32 | $9.91 | +222.99% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $155 → $82 | $83.67 | -2.00% | 3 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $22 | $14.64 | +50.27% | 3 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $8.83 | +103.85% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $12 | $6.87 | +74.67% | 9 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 → $165 | $116.96 | +41.07% | 10 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5.5 → $3.5 | $3.97 | -11.84% | 7 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $255 → $140 | $133.30 | +5.03% | 5 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $285 → $310 | $160.02 | +93.73% | 8 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $250 → $330 | $324.82 | +1.59% | 13 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $50 | $27.34 | +82.87% | 3 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $40 → $16 | $25.48 | -37.21% | 7 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $115 | $57.15 | +101.22% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $9 → $12 | $4.23 | +183.69% | 7 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $380 → $420 | $315.13 | +33.28% | 12 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $25 | $11.93 | +109.56% | 1 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $3 | $0.82 | +265.85% | 2 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $4 → $4.5 | $3.46 | +30.06% | 2 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $80.07 | - | 2 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $3.80 | +294.74% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $93 → $109 | $61.34 | +77.29% | 1 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $100 → $80 | $16.90 | +373.37% | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $12 | $3.97 | +202.27% | 1 | Jun 24, 2020 |
Adagio Medical Holdings
Apr 14, 2026
Initiates: Overweight
Price Target: $3
Current: $1.05
Upside: +185.71%
Medtronic
Apr 1, 2026
Maintains: Neutral
Price Target: $105 → $91
Current: $79.37
Upside: +14.65%
MiniMed Group
Mar 31, 2026
Initiates: Neutral
Price Target: $16
Current: $12.02
Upside: +33.11%
TELA Bio
Mar 25, 2026
Maintains: Neutral
Price Target: $1.25 → $1
Current: $0.86
Upside: +16.28%
CONMED
Mar 17, 2026
Downgrades: Neutral
Price Target: $55 → $39
Current: $35.96
Upside: +8.45%
Tandem Diabetes Care
Mar 17, 2026
Upgrades: Overweight
Price Target: $21 → $33
Current: $18.16
Upside: +81.72%
PROCEPT BioRobotics
Feb 26, 2026
Maintains: Overweight
Price Target: $50 → $28
Current: $21.71
Upside: +28.97%
TransMedics Group
Feb 25, 2026
Maintains: Overweight
Price Target: $140 → $160
Current: $98.57
Upside: +62.32%
Globus Medical
Jan 8, 2026
Reiterates: Overweight
Price Target: $90 → $115
Current: $87.79
Upside: +30.99%
Kestra Medical Technologies
Dec 12, 2025
Maintains: Overweight
Price Target: $27 → $30
Current: $19.51
Upside: +53.77%
Nov 12, 2025
Reiterates: Overweight
Price Target: $18
Current: $12.28
Upside: +46.58%
Oct 31, 2025
Maintains: Overweight
Price Target: $100 → $75
Current: $57.56
Upside: +30.30%
Oct 31, 2025
Reiterates: Overweight
Price Target: $20 → $25
Current: $9.30
Upside: +168.82%
Oct 29, 2025
Reiterates: Overweight
Price Target: $26 → $32
Current: $9.91
Upside: +222.99%
Oct 24, 2025
Maintains: Overweight
Price Target: $155 → $82
Current: $83.67
Upside: -2.00%
Oct 10, 2025
Maintains: Overweight
Price Target: $30 → $22
Current: $14.64
Upside: +50.27%
Aug 18, 2025
Initiates: Overweight
Price Target: $18
Current: $8.83
Upside: +103.85%
May 9, 2025
Maintains: Overweight
Price Target: $20 → $12
Current: $6.87
Upside: +74.67%
Apr 15, 2025
Maintains: Overweight
Price Target: $180 → $165
Current: $116.96
Upside: +41.07%
Mar 6, 2025
Maintains: Neutral
Price Target: $5.5 → $3.5
Current: $3.97
Upside: -11.84%
Feb 28, 2025
Downgrades: Neutral
Price Target: $255 → $140
Current: $133.30
Upside: +5.03%
Feb 21, 2025
Maintains: Overweight
Price Target: $285 → $310
Current: $160.02
Upside: +93.73%
Feb 19, 2025
Reiterates: Overweight
Price Target: $250 → $330
Current: $324.82
Upside: +1.59%
Feb 13, 2025
Maintains: Overweight
Price Target: $40 → $50
Current: $27.34
Upside: +82.87%
Feb 12, 2025
Maintains: Neutral
Price Target: $40 → $16
Current: $25.48
Upside: -37.21%
Feb 3, 2025
Maintains: Overweight
Price Target: $95 → $115
Current: $57.15
Upside: +101.22%
Nov 8, 2024
Reiterates: Neutral
Price Target: $9 → $12
Current: $4.23
Upside: +183.69%
Oct 30, 2024
Reiterates: Overweight
Price Target: $380 → $420
Current: $315.13
Upside: +33.28%
Mar 28, 2024
Initiates: Overweight
Price Target: $25
Current: $11.93
Upside: +109.56%
Nov 10, 2023
Maintains: Neutral
Price Target: $3.5 → $3
Current: $0.82
Upside: +265.85%
Aug 11, 2023
Maintains: Overweight
Price Target: $4 → $4.5
Current: $3.46
Upside: +30.06%
Mar 10, 2023
Upgrades: Overweight
Price Target: n/a
Current: $80.07
Upside: -
Feb 24, 2023
Initiates: Overweight
Price Target: $15
Current: $3.80
Upside: +294.74%
Feb 11, 2021
Maintains: Overweight
Price Target: $93 → $109
Current: $61.34
Upside: +77.29%
Jan 29, 2021
Downgrades: Neutral
Price Target: $100 → $80
Current: $16.90
Upside: +373.37%
Jun 24, 2020
Initiates: Overweight
Price Target: $12
Current: $3.97
Upside: +202.27%